[ZVRA] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ZVRA] Zevra Therapeutics, Inc.
Announcement Date
30-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 72.48%
YoY- -276.12%
Quarter Report
ZVRA's Result
ZVRA's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 8,470 2,879 2,319 2,874 1,300 3,965 2,582 121.25%
PBT -5,158 -11,870 -9,055 -6,649 -24,757 -1,868 -2,669 55.33%
Tax -74 -103 -34 -33 -715 -4 34 -
NP -5,084 -11,767 -9,021 -6,616 -24,042 -1,864 -2,703 52.54%
Tax Rate - - - - - - - -
Total Cost 13,554 14,646 11,340 9,490 25,342 5,829 5,285 87.68%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -60.02 -408.72 -389.00 -230.20 -1,849.38 -47.01 -104.69 -31.05%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.15 -0.34 -0.26 -0.19 -0.70 -0.05 -0.08 52.23%
EPS Diluted -0.15 -0.34 -0.26 -0.19 -0.70 -0.05 -0.08 52.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.